Average Co-Inventor Count = 4.70
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Sangamo Therapeutics, Inc. (16 from 147 patents)
2. Sangamo Biosciences, Inc. (6 from 160 patents)
3. The University of Texas System (3 from 5,499 patents)
4. University of Washington (2 from 2,114 patents)
5. City of Hope (2 from 645 patents)
6. Children's Medical Center Corporation (1 from 1,041 patents)
22 patents:
1. 11884930 - Method of inactivating a glucocorticoid receptor gene in an isolated cell
2. 11492643 - Methods and compositions for treatment of a genetic condition
3. 11235026 - Methods and compositions for modulating PD1
4. 11021696 - Nuclease-mediated regulation of gene expression
5. 10907175 - Isolated human cell with an inactivated glucocorticoid receptor gene
6. 10858416 - Methods and compositions for modification of a HLA locus
7. 10808020 - Nuclease-mediated regulation of gene expression
8. 10619154 - Nuclease-mediated regulation of gene expression
9. 10196651 - Methods and compositions for treatment of a genetic condition
10. 10196652 - Methods and compositions for treatment of a genetic condition
11. 10072062 - Methods and compositions for modification of a HLA locus
12. 10072066 - Methods and compositions for treatment of a beta thalessemia
13. 10046028 - Methods and compositions for modulating PD1
14. 9963715 - Methods and compositions for treatment of a genetic condition
15. 9957501 - Nuclease-mediated regulation of gene expression